MP Healthcare Venture Management

About The Fund

MP Healthcare Venture Management (MPH) is a venture capital firm specializing in seed and early-stage investments within the life sciences sector. Founded in 2006 and operating as a subsidiary of Mitsubishi Tanabe Pharma Corporation, MPH focuses on empowering healthcare entrepreneurs by developing novel technologies and therapeutics in several key areas of the healthcare industry. Their investment scope includes biotechnology, medical devices, hospital services, healthcare and wellness, investment management, pharmaceuticals, and medicine. Based in Boston, Massachusetts, MPH has set out an investment range with a minimum of $100,000, a maximum of $5,000,000, and a sweet spot of around $1,500,000. MPH is known for its support in various development stages, including Early, Seed, Series A, and Series B funding. By collaborating closely with healthcare startups, MPH provides not only financial support but also strategic guidance, leveraging its extensive network and expertise to foster innovation and growth. The firm's commitment is illustrated through their hands-on approach to working with portfolio companies, such as Ribometrix, F-star, and QurAlis, which have benefited significantly from MPH’s investment and support in their formative stages. The testimony from the co-founders of these companies highlights MPH's instrumental role in their success and the value of their partnership. MPH's active portfolio reflects their mission to help build tomorrow's life science companies, making a tangible impact in the field of healthcare through strategic investment and partnership.